COMPANIES

ImmunityBio (IBRX) Stock Explodes 500%+ in 2026 on ANKTIVA's 700% Revenue Surge

ImmunityBio
ImmunityBio Inc.'s stock has skyrocketed in early 2026, surging more than 500% year-to-date and hitting new 52-week highs above $11 as explosive sales growth for its flagship immunotherapy ANKTIVA, coupled with rapid international regulatory approvals and partnerships, fuels investor enthusiasm for the cancer-focused biotech.
More news
Satoshi

Satoshi Stacker: The Entrepreneur Building A Digital Utopia

With a vision that transcends traditional business, Stacker is aiming to create a self-sustaining, decentralized digital society where governance, finance, and innovation operate independently of traditional institutions.
Elevator

Next Level Elevators Brings Exclusive Italian Elevator Brand To Australian Homes

Next Level Elevators transforms Australian homes with premium Italian-engineered elevator solutions, offering families unparalleled flexibility and elegance. Its best-selling elevator, the Eltec HLB, embodies customisable luxury, allowing homeowners to tailor every aspect, from cabin size to finishes.

Pages

  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • Next